Drug Information Association Logo

Barbara Lopez Kunz Takes the Reins as DIA’s Global Chief Executive

WASHINGTON — Sep 11, 2013

DIA today announced that Barbara Lopez Kunz has begun leading the organization as global chief executive. Kunz brings her exceptional worldwide leadership experience to DIA as former president of the Global Health and Life Sciences business at Battelle, an international science and technology nonprofit organization that explores emerging areas of science, develops and commercializes technology, and manages laboratories.

“DIA is excited to have Barbara now leading the way and utilizing her international knowledge and leadership skills to ensure that DIA remains the global forum fostering innovation to raise the level of health and well-being worldwide,” DIA President Minnie Baylor-Henry said. “Barbara has a remarkably successful track record of growing businesses that are based on innovation in science and technology and implementing globally effective strategies, and we are looking forward to her leadership and guidance.”

In her role with Battelle, Kunz transformed the Global Health and Life Sciences business through strategic investments, alliance development and technology commercialization, increasing the number of research collaborations with industrial, government and academic sponsors. She has also held senior roles at Thermo Fisher Scientific (formerly Fisher Scientific International), Croda International (formerly ICI), DuPont and PPG Industries, after starting her career as a research scientist.

A leader on numerous corporate and nonprofit boards, she has presided over the board of The Ohio State University Wexner Medical Center and is a trustee of both The Research Institute at Nationwide Children’s Hospital and BioOhio, the statewide organization stimulating economic development in the bioscience community. Kunz is a member of the Healthcare Businesswomen’s Association Ohio chapter advisory board.

“I am excited to begin leading DIA into its 50th year, and build upon nearly a half century of momentum in advancing innovation worldwide. The foundation is in place to apply my knowledge of patient needs and the health care community and to fortify DIA’s significant role in transferring vital information across the globe,” Kunz said.

For more information, please go to www.diahome.org. To arrange an interview with Kunz or to request a headshot or complete biography, please contact Judy Connors at +1.215.293.5860 or Judy.Connors@diahome.org.

 

 

 

###

ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.